Product Name: Human IL-2RA Antibody (Daclizumab, Research Use)
Catalog Number: NBR-0223
Target Name: IL-2RA
Trade Name: Daclizumab
Antibody Drug Description: Daclizumab (DAC) is a humanized, monoclonal antibody that blocks CD25, a critical element of the high-affinity interleukin-2 receptor (IL-2R). DAC HYP blockade of CD25 inhibits effector T cell activation, regulatory T cell expansion and survival, and activation-induced T-cell apoptosis. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: IL-2RA
Synonyms: CD25; IDDM10; IL2R
Target Description: Receptor for interleukin-2. The receptor is involved in the regulation of immune tolerance by controlling regulatory T cells (TREGs) activity. TREGs suppress the activation and expansion of autoreactive T-cells.
Ensembl: ENSG00000134460 
Uniprot: P01589